Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...
Beaten Down Under Biden, Big Pharma Hopes for New Chapter Under Trump
With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.
stocknews6d
3 Under-the-Radar Biotech Stocks Revolutionizing Healthcare
Hidden gems in the biotech sector are reshaping healthcare with breakthroughs in personalized medicine and rare disease ...
ANI Pharmaceuticals To Present At The Guggenheim Biotech Conference
The live and archived webcast will be accessible from the Company's website at , under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 60 days.
Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock with Biggest Upside Potential
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...